Cite
HARVARD Citation
Stynes, G. et al. (2015). Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy. Respiratory research. 16 (1), pp. 1-11. [Online].